Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed about a transcript of the conference call held to discuss the Companys unaudited financial results for Quarter/Nine Months ended December 31, 2017, on Friday, February 09, 2018 at 02.30 pm local time. Velumani A., Ph.D., CEO, A. Sundararaju, CFO, Sachin Salvi, GM-Finance and Vatsal Goyal, Head-Strategy & Corporate Development, represented the Company.
The above information is a part of company’s filings submitted to BSE.
